REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12/08/2025
Back to search
Official data from USPTO
WMBIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
12/09/2025
Trademark type
Combined
Nice classes
5, 42
Filing date
11/05/2019
Registration date
12/08/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/08/2020
Last transaction
12/09/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
KR
Examiner
MACFARLANE,JAMES W
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "WMBIO" in a gray stylized font, beneath the design of a stylized tree in brown, comprised of a rounded hexagonal shape with a vertical line ending in thee prongs travelling from the bottom of the hexagonal shape to its middle, and with pointed ovals of different sizes alternating in a circular format around the end of the line within the hexagonal shape, representing the leaves of the tree.
Holders and representatives
Holders
Wellmarker Bio Co., LTD.
Representatives
Richard Y. Kim Snell & Wilmer L.L.P.
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical agents affecting sensory organs; vaccines; vitamin preparations; nervines in the nature of pharmaceutical preparations to calm the nerves; digestives for pharmaceutical purposes; alcohol for pharmaceutical purposes; pharmaceutical agents for epidermis; biological preparations for medical purposesfor treating cancerdiabetes and skin disorders; biological preparations for veterinary purposesfor treating cancerdiabetesskin disorders; drugs for medical purposesfor treating cancerdiabetesskin disorders; medicinal hair growth preparations; pharmaceuticals for humansfor treating cancerdiabetesskin disorders; pharmaceutical preparations for treating cancerdiabetesskin disorders; veterinary preparations for treating cancerdiabetesskin disorders; pharmaceutical preparations acting on the central nervous systemfor treating cancerdiabetesskin disorders; therapeutic drugs and agents for treating cancerdiabetesskin disorders; antibiotic preparations; implants comprising living tissue; medical diagnostic test strips for biomarker analysisblood analysisurine analysissaliva analysis; bandages for dressings; adhesive bands for medical purposes; materials for dental fillings and for stopping teeth
Class 42
Research and development of vaccines and medicines; development of cell therapy products; scientific research for medical purposes in the field of cancerous diseases; pharmaceutical products development; research on the subject of pharmaceuticals; medical product testing; scientific research for medical products; scientific research in the fields of medicinehealth and pharmacology; clinical trialsproduct testing in the field of pharmaceuticals; medical research; medical research in the field of crude medicines; bacteriological research; drug discovery services; clinical testing of medicines in the nature of product testing; industrial research in the fields of medicinehealth and pharmacology; scientific research in the field of pharmacy; testinginspection or research of pharmaceuticalscosmetics or foodstuff; medical and scientific research services in the field of cosmetics; research and development of new products; biotechnology research; genetic research; medical and scientific research involving DNA testing; medical and scientific research and product development in the field of DNA chips; medical and scientific research involving the structural and functional analysis of genomes; DNA screening for scientific research purposes; genetic testing for scientific research purposes; scientific research conducted using databases; medical and scientific research involving molecular analysis; product research and development of technology for biotechnology; consultancy in the field of biotechnology; advisory services relating to biotechnology; biotechnology servicesbiotechnology research; genetic testing for scientific research purposes involving biological information checks; genetic testing for medical research purposes involving biological information checks; product research and development of medical apparatus and instruments for others; providing technical support servicestroubleshooting in the nature of diagnosing problems with medical diagnostic instruments; development of computer software for big data processing; developmentupdating and maintenance of software and database systems; computer programming in the medical field; providing computer software technical support services in the field of medical diagnostics; DNA analysis for scientific research purposes; DNA sequence analysis for scientific research purposes
Publications
History of USPTO decisions and trademark events.
22 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/04/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/13/2021
FIMP
FINAL DISPOSITION PROCESSED
03/13/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/08/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
12/08/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/22/2020
PUBO
PUBLISHED FOR OPPOSITION
09/22/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/02/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/18/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/29/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/29/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/29/2020
RFNT
REFUSAL PROCESSED BY IB
03/27/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/12/2020
RFRR
REFUSAL PROCESSED BY MPU
03/12/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/20/2020
CNRT
NON-FINAL ACTION WRITTEN
02/19/2020
DOCK
ASSIGNED TO EXAMINER
02/09/2020
MAFR
APPLICATION FILING RECEIPT MAILED
12/17/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/13/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/12/2019
Continuous trademark protection
Get notified about every new filing that threatens WMBIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.